Currently does not cover obesity medications even with prior authorization
Subsequently, Moore proposed the hypothesis that intestinal secretions might have a glycemic-lowering effect in diabetics, which was the first study to suggest an effect of intestinal secretions on blood glucose (Moore, 1906), and in the 1960s a team of researchers in the UK and the US independently discovered the incretin effect, in which oral glucose markedly stimulates insulin secretion, setting the stage for the subsequent development of incretin (Elrick et al., 1964
Available online at: (Accessed June 12, 2025)
The stress response to surgery typically raises blood glucose levels, making perioperative diabetes management a careful balance
Mechanism and implications of advanced glycation end products (AGE) and its receptor RAGE axis as crucial mediators linking inflammation and obesity
Phase III retatrutide study demonstrates 30% weight loss. May 22, 2026